@yiyuantan.bsky.social
Gastroenterologist in Singapore with an interest in IBD
Progress towards personalised #IBD therapy will require granularity re: genetic contributions, with a push for 4 digit HLA resolution.
Risk of Anti-TNF immunogenecity (mitigated by IMM):
DQA1*05:01 - IFX
DQA1*05:05 - IFX , ADA+
DRB1*01:02 - ADA ++
Risk of Anti-TNF immunogenecity (mitigated by IMM):
DQA1*05:01 - IFX
DQA1*05:05 - IFX , ADA+
DRB1*01:02 - ADA ++
November 20, 2024 at 8:39 AM
Progress towards personalised #IBD therapy will require granularity re: genetic contributions, with a push for 4 digit HLA resolution.
Risk of Anti-TNF immunogenecity (mitigated by IMM):
DQA1*05:01 - IFX
DQA1*05:05 - IFX , ADA+
DRB1*01:02 - ADA ++
Risk of Anti-TNF immunogenecity (mitigated by IMM):
DQA1*05:01 - IFX
DQA1*05:05 - IFX , ADA+
DRB1*01:02 - ADA ++